SCM
MRK icon

SOL Capital Management’s Merck MRK Stock Holding History

SOL Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,858
Closed -$511K – 214
2025
Q4 		$511K Buy
4,858
+88
+2% +$8.26K 0.05% 236
2025
Q3 		$400K Buy
4,770
+346
+8% +$28.5K 0.04% 250
2025
Q2 		$350K Sell
4,424
-67
-1% -$5.33K 0.03% 257
2025
Q1 		$403K Buy
4,491
+100
+2% +$9.34K 0.04% 244
2024
Q4 		$437K Sell
4,391
-166
-4% -$17.1K 0.05% 239
2024
Q3 		$517K Buy
4,557
+100
+2% +$11.9K 0.06% 225
2024
Q2 		$552K Hold
4,457
– – 0.07% 217
2024
Q1 		$588K Hold
4,457
– – 0.07% 210
2023
Q4 		$486K Sell
4,457
-10
-0.2% -$1.04K 0.07% 224
2023
Q3 		$460K Buy
4,467
+715
+19% +$77.1K 0.07% 215
2023
Q2 		$433K Sell
3,752
-180
-5% -$20.4K 0.07% 215
2023
Q1 		$418K Hold
3,932
– – 0.07% 218
2022
Q4 		$436K Sell
3,932
-150
-4% -$15.3K 0.08% 210
2022
Q3 		$352K Sell
4,082
-75
-2% -$6.7K 0.07% 209
2022
Q2 		$379K Sell
4,157
-19
-0.5% -$1.68K 0.08% 204
2022
Q1 		$343K Sell
4,176
-500
-11% -$39.4K 0.06% 214
2021
Q4 		$358K Hold
4,676
– – 0.06% 214
2021
Q3 		$351K Hold
4,676
– – 0.07% 210
2021
Q2 		$364K Sell
4,676
-198
-4% -$14.7K 0.07% 204
2021
Q1 		$359K Hold
4,874
– – 0.08% 193
2020
Q4 		$380K Hold
4,874
– – 0.09% 181
2020
Q3 		$386K Hold
4,874
– – 0.11% 165
2020
Q2 		$360K Hold
4,874
– – 0.1% 171
2020
Q1 		$358K Hold
4,874
– – 0.12% 160
2019
Q4 		$423K Buy
4,874
+36
+0.7% +$2.96K 0.11% 173
2019
Q3 		$389K Sell
4,838
-648
-12% -$51.9K 0.11% 182
2019
Q2 		$439K Hold
5,486
– – 0.12% 171
2019
Q1 		$435K Sell
5,486
-241
-4% -$18K 0.12% 174
2018
Q4 		$418K Sell
5,727
-176
-3% -$12.4K 0.13% 161
2018
Q3 		$400K Sell
5,903
-79
-1% -$5.03K 0.11% 181
2018
Q2 		$346K Buy
5,982
+241
+4% +$13.6K 0.1% 193
2018
Q1 		$298K Buy
5,741
+439
+8% +$23.7K 0.09% 202
2017
Q4 		$285K Sell
5,302
-1,048
-17% -$58.1K 0.08% 209
2017
Q3 		$388K Sell
6,350
-105
-2% -$6.37K 0.11% 188
2017
Q2 		$395K Buy
6,455
+141
+2% +$8.58K 0.11% 180
2017
Q1 		$383K Sell
6,314
-53
-0.8% -$3.21K 0.11% 174
2016
Q4 		$358K Sell
6,367
-262
-4% -$15.3K 0.11% 169
2016
Q3 		$395K Hold
6,629
– – 0.13% 144
2016
Q2 		$364K Hold
6,629
– – 0.12% 145
2016
Q1 		$335K Sell
6,629
-157
-2% -$7.69K 0.11% 151
2015
Q4 		$342K Sell
6,786
-105
-2% -$5.29K 0.12% 149
2015
Q3 		$325K Sell
6,891
-104
-1% -$5.53K 0.13% 145
2015
Q2 		$380K Sell
6,995
-480
-6% -$26.9K 0.14% 137
2015
Q1 		$410K Sell
7,475
-210
-3% -$11.9K 0.15% 130
2014
Q4 		$416K Hold
7,685
– – 0.16% 122
2014
Q3 		$435K Sell
7,685
-786
-9% -$44.1K 0.18% 117
2014
Q2 		$468K Sell
8,471
-524
-6% -$28.6K 0.19% 112
2014
Q1 		$487K Sell
8,995
-969
-10% -$50.2K 0.19% 105
2013
Q4 		$476K Sell
9,964
-324
-3% -$14.8K 0.18% 103
2013
Q3 		$467K Sell
10,288
-315
-3% -$14.4K 0.19% 102
2013
Q2 		$470K Buy
+10,603
New +$474K 0.19% 102

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SOL Capital Management's MRK Position: Q1 2026 in Review

SOL Capital Management sold out of Merck (MRK) in Q1 2026, closing a stake of 4,858 shares — an estimated $511K sold.

SOL Capital Management first reported a position in MRK in Q2 2013 and held it in 51 quarters. The position peaked at $588K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • SOL Capital Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • SOL Capital Management sold 4,858 Merck shares in Q1 2026, an estimated $511K.
  • SOL Capital Management first reported a position in Merck in Q2 2013 and held it in 51 quarters.
  • SOL Capital Management's Merck position peaked at $588K in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on SOL Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.